HLN
Haleon plc · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -6.8% · netto nieuwe posities 0.0% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 142.53K | $1.29M | n/a | −1 |
| Q2 2026 | 103 | +5 | 528.15M | $4.87B | +8 | −4 |
| Q1 2026 | 100 | +1 | 506.60M | $5.01B | +6 | −6 |
| Q4 2025 | 99 | -2 | 494.67M | $4.94B | +1 | −2 |
| Q3 2025 | 16 | -1 | 341.18M | $3.06B | +1 | −3 |
| Q2 2025 | 15 | 0 | 306.18M | $3.18B | +2 | −2 |
| Q1 2025 | 13 | 0 | 210.33M | $2.16B | n/a | n/a |
| Q4 2024 | 13 | +1 | 208.23M | $1.99B | +2 | −1 |
| Q3 2024 | 11 | 0 | 206.41M | $2.18B | +2 | −2 |
| Q2 2024 | 11 | n/a | 210.64M | $1.74B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 155.47M | -8.1% | $1.61B | 0.9% | ▼ Trim | 5 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 111.76M | n/a | $1.16B | 0.1% | n/c | 1 | SEC ↗ ×4 |
| 3 | Wellington Management ✦ | 16.69M | -10.8% | $173.03M | 0.0% | ▼ Trim | 5 | SEC ↗ ×6 |
| 4 | Renaissance Technologies ✦ | 7.79M | +528.1% | $80.75M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 6.42M | n/a | $66.61M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 6 | Citadel Advisors ✦ | 4.57M | -23.6% | $47.40M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 7 | Millennium Management ✦ | 2.15M | -49.0% | $22.30M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Fisher Asset Management ✦ | 354.04K | -8.5% | $3.67M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 9 | State Street Global Advisors ✦ (passief) | 312.90K | -3.9% | $3.24M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Norges Bank ✦ (passief) | 275.00K | Nieuw | $2.85M | 0.0% | New | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 128.10K | +33.0% | $1.33M | 0.0% | ▲ Add | 4 | SEC ↗ ×3 |
| 12 | Point72 Asset Management ✦ | 89.40K | -98.7% | $927,078 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Tweedy, Browne ✦ | 76.81K | -5.7% | $796,478 | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 14 | Marshall Wace ✦ | 60.94K | Nieuw | $631,989 | 0.0% | New | 1 | SEC ↗ ×2 |
| 15 | Two Sigma Investments ✦ | 35.84K | -69.0% | $371,630 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Norges Bank | $2.85M | 0.0% |
| Marshall Wace | $631,989 | 0.0% |
Verlaten
| Arrowstreet Capital | $25.89M | was 0.0% |
| D. E. Shaw & Co. | $9.40M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 618 houders, 559.47M aandelen, $5.40B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.